Effect of rilmenidine on baroreflex control of renal sympathetic nerve activity.
Sannajust
F
F
Baker Medical Research Institute, Department of Neuropharmacology, Prahran, Victoria, Australia.
Head
G A
GA
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D017704:Baroreflex / Q000187:drug effects* / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004146:Dioxanes / Q000494:pharmacology; D005260:Female; D019329:Idazoxan; D054755:Imidazoline Receptors; D007668:Kidney / Q000187:drug effects* / Q000294:innervation*; D008297:Male; D010080:Oxazoles / Q000494:pharmacology*; D011817:Rabbits; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects / Q000502:physiology; D011955:Receptors, Drug / Q000187:drug effects / Q000502:physiology; D000077769:Rilmenidine; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D054755:Imidazoline Receptors; D010080:Oxazoles; D018341:Receptors, Adrenergic, alpha-2; D011955:Receptors, Drug; D000077769:Rilmenidine; D019329:Idazoxan